Promising New Treatment Boosts Survival Rates In Pediatric Cancer

The approach targets neuroblastomas, a rare form of cancer which develops in nerve cells.

Related Keywords

Abdullah Mir ,University Of Birmingham ,International Society Of Paediatric Oncology European Neuroblastoma ,International Society ,Paediatric Oncology European Neuroblastoma ,Innovative Therapies ,Clinical Trials ,Clinical Trial ,Neuroblastoma ,Anti Tumor Drugs ,Chemotherapy ,Anti Angiogenic Drugs ,Tumor Shrinkage ,One Year Progression Free Survival ,Bevacizumab ,Collaborative Research ,Pediatric Oncology ,